Clinical trial
A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
NCT06099535
Study timeline
Study start (actual)2021-11-18Date precision: day
Registry last updated2023-10-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
Sponsors & collaborators
Lynk Pharmaceuticals Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06099535 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.